Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$580M |
| 2 |
Broadcom
AVGO
|
+$511M |
| 3 |
Tesla
TSLA
|
+$471M |
| 4 |
American International
AIG
|
+$438M |
| 5 |
Advanced Micro Devices
AMD
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$444M |
| 2 |
Synopsys
SNPS
|
+$348M |
| 3 |
Pinduoduo
PDD
|
+$326M |
| 4 |
NetEase
NTES
|
+$314M |
| 5 |
DexCom
DXCM
|
+$302M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.37% |
| 2 | Financials | 12.15% |
| 3 | Industrials | 11.37% |
| 4 | Healthcare | 11.18% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Monte Rosa Therapeutics
GLUE
$1.92B
| $59.4K | ﹤0.01% |
+10,518
| New | +$41.3K |
|
3627
Actinium Pharmaceuticals
ATNM
$26.3M
| $58.7K | ﹤0.01% |
11,561
-22,049
| -66% | -$114K |
|
|
MOND
3628
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $55.8K | ﹤0.01% |
20,222
-2,159
| -10% | -$7.69K |
|
3629
Larimar Therapeutics
LRMR
$397M
| $55.8K | ﹤0.01% |
+12,258
| New | +$41.4K |
|
3630
DHI Group
DHX
$176M
| $54.9K | ﹤0.01% |
21,205
-16,168
| -43% | -$41.6K |
|
|
PPTA
3631
Perpetua Resources
PPTA
$2.37B
| $53.2K | ﹤0.01% |
16,769
-2,518
| -13% | -$8.49K |
|
|
IVAC
3632
DELISTED
Intevac Inc
IVAC
| $52.8K | ﹤0.01% |
+12,212
| New | +$45.5K |
|
3633
BioAtla
BCAB
$5.61M
| $52K | ﹤0.01% |
423
+66
| +18% | +$5.72K |
|
3634
ProKidney
PROK
$324M
| $51.5K | ﹤0.01% |
28,936
-11,710
| -29% | -$25.1K |
|
3635
Cadiz
CDZI
$264M
| $50.1K | ﹤0.01% |
17,885
-33,112
| -65% | -$99.9K |
|
3636
Denison Mines
DNN
$2.64B
| $49.8K | ﹤0.01% |
28,113
+1,407
| +5% | +$2.35K |
|
|
KYNB
3637
Kyntra Bio
KYNB
$27.5M
| $49.1K | ﹤0.01% |
2,216
-1,666
| -43% | -$25.1K |
|
|
CMAX
3638
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $48.3K | ﹤0.01% |
3,229
+257
| +9% | +$10.7K |
|
3639
Protalix BioTherapeutics
PLX
$183M
| $47.9K | ﹤0.01% |
26,884
-29,531
| -52% | -$45.9K |
|
3640
Dakota Gold
DC
$624M
| $46.8K | ﹤0.01% |
17,872
-777
| -4% | -$2.09K |
|
|
IDEX
3641
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $45.3K | ﹤0.01% |
22,782
+272
| +1% | +$562 |
|
3642
Citius Pharmaceuticals
CTXR
$17.4M
| $44.1K | ﹤0.01% |
2,332
+370
| +19% | +$7.02K |
|
3643
Aveanna Healthcare
AVAH
$2.11B
| $42.3K | ﹤0.01% |
15,798
+2,823
| +22% | +$5.38K |
|
3644
Bionano Genomics
BNGO
$12.2M
| $42K | ﹤0.01% |
371
-138
| -27% | -$14.4K |
|
|
OPTN
3645
DELISTED
OptiNose
OPTN
| $41.8K | ﹤0.01% |
2,158
-450
| -17% | -$8.21K |
|
3646
BioXcel Therapeutics
BTAI
$24.5M
| $41.7K | ﹤0.01% |
+884
| New | +$49.1K |
|
3647
Tenaya Therapeutics
TNYA
$163M
| $41.2K | ﹤0.01% |
+12,719
| New | +$27.5K |
|
|
AMRN
3648
Amarin Corp
AMRN
$298M
| $41.2K | ﹤0.01% |
2,368
+467
| +25% | +$7.33K |
|
3649
Paysign
PAYS
$512M
| $40.6K | ﹤0.01% |
14,497
-73,994
| -84% | -$162K |
|
3650
Vor Biopharma
VOR
$1.18B
| $40.6K | ﹤0.01% |
902
+176
| +24% | +$7.26K |
|
Similar funds
Invesco's Q4 2023 Portfolio in Review
As of Q4 2023, Invesco held 3,965 positions worth $420B, up 13% from $371B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Invesco's Q4 2023 filing shows 126 new, 1,970 increased, 1,592 reduced and 143 closed positions. Its largest new stake was Veralto: 4,358,553 shares worth $359M. The largest sale was Pioneer Natural Resource Co., an estimated $444M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q4 2023 buy was Veralto: 4,358,553 shares worth $359M.
- Invesco added most to Texas Instruments in Q4 2023, an estimated $580M increase.
- Invesco's biggest Q4 2023 reduction was Pioneer Natural Resource Co., cutting an estimated $444M.
- Invesco fully exited Activision Blizzard in Q4 2023, selling an estimated $186M.
- Invesco's ten largest holdings make up 15% of its $420B portfolio in Q4 2023.
- Invesco opened 126 new positions and closed 143 in Q4 2023.
- Invesco's portfolio value rose 13% quarter-over-quarter to $420B.
Based on Invesco's 13F filing for Q4 2023, filed 13 Feb 2024.